ATE59549T1 - Verpamil in dosierungskapsel. - Google Patents

Verpamil in dosierungskapsel.

Info

Publication number: ATE59549T1
Authority: AT; Austria
Prior art keywords: verpamil; dosage capsule; capsule; dosage; verapamil
Prior art date: 1986-03-19

Application number

AT87301155T

Other languages

English (en)

Inventor

Sally I Stephens

Paul Magruder

Patrick S-L Wong

Larry G Hamel

Original Assignee

Alza Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-03-19

Filing date

1987-02-10

Publication date

1991-01-15

1987-02-10 Application filed by Alza Corp filed Critical Alza Corp

1991-01-15 Application granted granted Critical

1991-01-15 Publication of ATE59549T1 publication Critical patent/ATE59549T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AT87301155T 1986-03-19 1987-02-10 Verpamil in dosierungskapsel. ATE59549T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US06/841,144 US4753802A (en)	1986-03-19	1986-03-19	Verapamil dosage form
EP87301155A EP0238189B1 (de)	1986-03-19	1987-02-10	Verpamil in Dosierungskapsel

Publications (1)

Publication Number	Publication Date
ATE59549T1 true ATE59549T1 (de)	1991-01-15

Family

ID=25284138

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT87301155T ATE59549T1 (de)	1986-03-19	1987-02-10	Verpamil in dosierungskapsel.

Country Status (12)

Country	Link
US (1)	US4753802A (de)
EP (1)	EP0238189B1 (de)
JP (1)	JPH0798748B2 (de)
KR (1)	KR900003385B1 (de)
AT (1)	ATE59549T1 (de)
AU (1)	AU587307B2 (de)
CA (1)	CA1261703A (de)
DE (1)	DE3766858D1 (de)
ES (1)	ES2019632B3 (de)
GR (1)	GR3001290T3 (de)
MX (1)	MX174161B (de)
ZA (1)	ZA871031B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4690683A (en) *	1985-07-02	1987-09-01	Rutgers, The State University Of New Jersey	Transdermal varapamil delivery device
US4816263A (en) *	1987-10-02	1989-03-28	Alza Corporation	Dosage form for treating cardiovascular diseases comprising isradipine
US4859470A (en) *	1988-06-02	1989-08-22	Alza Corporation	Dosage form for delivering diltiazem
EP0455648B1 (de) *	1989-01-30	1993-03-10	Alza Corporation	Dosisform zur verabreichung von calciumantagonisten
HU205851B (en) *	1989-01-31	1992-07-28	Int Pharma Agentur	Systhem of regulated release of the active components and process for producing it
DD295760A5 (de) *	1989-01-31	1991-11-14	Martin-Luther-Universitaet Halle Wittenberg,De	Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
US5364635A (en) *	1989-09-28	1994-11-15	Knoll Ag	Solid drug form with a high verapamil content
NZ238867A (en) *	1990-07-12	1993-08-26	Alza Corp	Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
US6764697B1 (en)	1991-06-27	2004-07-20	Alza Corporation	System for delaying drug delivery up to seven hours
US5160744A (en) *	1991-06-27	1992-11-03	Alza Corporation	Verapmil therapy
US5435998A (en) *	1994-08-03	1995-07-25	Abelson; Mark B.	Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents
US5695781A (en) *	1995-03-01	1997-12-09	Hallmark Pharmaceuticals, Inc.	Sustained release formulation containing three different types of polymers
US6083532A (en)	1995-03-01	2000-07-04	Duramed Pharmaceuticals, Inc.	Sustained release formulation containing three different types of polymers and tablet formed therefrom
US6096339A (en) *	1997-04-04	2000-08-01	Alza Corporation	Dosage form, process of making and using same
UA74141C2 (uk)	1998-12-09	2005-11-15	Дж.Д. Сірл Енд Ко.	Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
US20060153914A1 (en) *	1999-12-10	2006-07-13	Biovail Laboratories International S.R.L.	Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en)	1999-12-10	2006-09-19	Biovall Laboratories International Srl	Chronotherapeutic diltiazem formulations and the administration thereof
JP4848101B2 (ja) *	2001-08-17	2011-12-28	株式会社フジモト・コーポレーション	徐放性マイクロペレット
US20040005359A1 (en) *	2002-06-27	2004-01-08	Cheng Xiu Xiu	Controlled release oral dosage form
JP2007512350A (ja) *	2003-11-25	2007-05-17	エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド	カルベジロール組成物の治療および送達方法
US8734850B2 (en)	2003-11-25	2014-05-27	Flamel Technologies	Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
DE102005031868A1 (de) *	2005-07-04	2007-01-18	Biotronik Vi Patent Ag	Arzneimitteldepot zur parenteralen, insbesondere intravaskulären Arzneimittelfreisetzung
AU2011230778A1 (en) *	2010-03-23	2012-08-02	Aska Pharmaceutical Co., Ltd.	Solid preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4265874A (en) *	1980-04-25	1981-05-05	Alza Corporation	Method of delivering drug with aid of effervescent activity generated in environment of use
US4681583A (en) *	1982-12-20	1987-07-21	Alza Corporation	System for dispersing drug in biological environment
US4627850A (en) *	1983-11-02	1986-12-09	Alza Corporation	Osmotic capsule
GB2150830B (en) *	1983-12-05	1987-08-19	Alza Corp	Drug dispenser
CA1266827A (en) *	1984-06-20	1990-03-20	Merck & Co., Inc.	Controlled porosity osmotic pump

1986
- 1986-03-19 US US06/841,144 patent/US4753802A/en not_active Expired - Lifetime
1987
- 1987-02-09 KR KR1019870001023A patent/KR900003385B1/ko not_active IP Right Cessation
- 1987-02-10 ES ES87301155T patent/ES2019632B3/es not_active Expired - Lifetime
- 1987-02-10 EP EP87301155A patent/EP0238189B1/de not_active Expired - Lifetime
- 1987-02-10 DE DE8787301155T patent/DE3766858D1/de not_active Expired - Lifetime
- 1987-02-10 AT AT87301155T patent/ATE59549T1/de not_active IP Right Cessation
- 1987-02-12 AU AU68715/87A patent/AU587307B2/en not_active Expired
- 1987-02-12 ZA ZA871031A patent/ZA871031B/xx unknown
- 1987-03-18 JP JP62063660A patent/JPH0798748B2/ja not_active Expired - Fee Related
- 1987-03-18 CA CA000532296A patent/CA1261703A/en not_active Expired
1991
- 1991-01-09 GR GR90400657T patent/GR3001290T3/el unknown
1992
- 1992-06-26 MX MX9203557A patent/MX174161B/es unknown

Also Published As

Publication number	Publication date
MX174161B (es)	1994-04-25
CA1261703A (en)	1989-09-26
AU587307B2 (en)	1989-08-10
MX9203557A (es)	1992-09-01
US4753802A (en)	1988-06-28
DE3766858D1 (de)	1991-02-07
GR3001290T3 (en)	1992-08-26
EP0238189A1 (de)	1987-09-23
ZA871031B (en)	1987-08-04
AU6871587A (en)	1987-09-24
KR900003385B1 (ko)	1990-05-18
ES2019632B3 (es)	1991-07-01
JPS62226924A (ja)	1987-10-05
JPH0798748B2 (ja)	1995-10-25
EP0238189B1 (de)	1991-01-02
KR870008594A (ko)	1987-10-19

Publication	Publication Date	Title
ATE59549T1 (de)	1991-01-15	Verpamil in dosierungskapsel.
NO883591D0 (no)	1988-08-12	Dermal administreringsform.
DE3778106D1 (de)	1992-05-14	Dosierungsform mit verzoegernder freisetzung.
IT8721411A0 (it)	1987-07-23	Composizione farmaceutica idrosolubile contenente n acetilsisteina.
NO890505L (no)	1989-09-26	Vandig blekepreparat.
DK165233C (da)	1993-03-08	Doseringsventil
KR880701523A (ko)	1988-11-03	N,n-디알킬알칸아미드로 되는 조성물 및 그 용도
DE3776541D1 (de)	1992-03-12	Taschentuchstapelvorrichtung.
IT8721410A0 (it)	1987-07-23	Composizione farmaceutica idrosolubile contenente n acetilcisteina.
DK150944C (da)	1988-06-27	Kombineret transport- og doseringspumpe
DE3576118D1 (de)	1990-04-05	Pharmazeutische praeparate.
DE3682960D1 (de)	1992-01-30	Pharmazeutische praeparate.
FR2611069B1 (fr)	1989-06-23	Calendrier posologique
DE3684096D1 (de)	1992-04-09	Halbleiterspeichervorrichtung und -matrixanordnung.
PT89883A (pt)	1989-11-10	Dispositivo administrador
FR2566662B1 (fr)	1989-03-10	Association medicamenteuse utilisee en photochimiotherapie
DE68910299D1 (de)	1993-12-02	Brotaufstrich.
TR23713A (tr)	1990-06-29	Suebstituye edilmis tiouereler,izotiouereler ve korbadiimetiller
ATE78161T1 (de)	1992-08-15	4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
FR2640378B1 (fr)	1991-02-22	Osmometre statique
NO894255D0 (no)	1989-10-25	Ny doseringsform.
ATE64535T1 (de)	1991-07-15	Xylometazolinhaltige pharmazeutische praeparate.
ATE63285T1 (de)	1991-05-15	Kombinierter kleidungs- und verpackungskoffer.
ATE50495T1 (de)	1990-03-15	Pharmazeutische praeparate.
BR6801705U (pt)	1988-11-01	Envelope

Legal Events

Date	Code	Title	Description
1991-06-15	UEP	Publication of translation of european patent specification
2007-05-15	EELA	Cancelled due to lapse of time